loading...

COA Instruments Distributed by Mapi Research Trust

default distrib

HAQ / Health Assessment Questionnaire Health Assessment Questionnaire

Fries JF et al.

To assess the difficulty in performing activities of daily living (Originally designed for adult arthritics, it has been used in a wide range of research settings)

Therapeutic indications : All, Generic for Musculoskeletal Diseases

default distrib

HDISS-DU / Hand Disability In Systemic Sclerosis - Digital Ulcers Hand Disability In Systemic Sclerosis - Digital Ulcers

Khanna D, Poiraudeau S, Gelhorn H, Papadakis K, Perchenet L, Mattera MS, Vernon M, Mouthon L, Hunsche E et al.

To capture the full spectrum of the impact of digital ulcers in patients and also to assess key symptoms and the impact of the disease on patients’ functioning from the patient perspective

Therapeutic indications : Scleroderma, Systemic

default distrib

I-PSS / International Prostate Symptom Score International Prostate Symptom Score

Barry MJ et al.

To capture the severity of urinary symptoms related to benign prostatic hyperplasia

Therapeutic indications : Benign Prostatic Hyperplasia

default distrib

IBHQ © / Impact of Bronchiolitis Hospitalisation Questionnaire Impact of Bronchiolitis Hospitalisation Questionnaire

Abbott (France) et al.

To comprehensively assess the impact of bronchiolitis hospitalization on parents, both just after hospital discharge and three months after hospital discharge

Therapeutic indications : Bronchiolitis

default distrib

IBS-GIS / Irritable Bowel Syndrome Global Improvement Scale Irritable Bowel Syndrome Global Improvement Scale

GlaxoSmithKline Research & Development Limited et al.

To assess multiple irritable bowel syndrome symptoms

Therapeutic indications : Irritable Bowel Syndrome

default distrib

IBS-QOL / Irritable Bowel Syndrome - Quality Of Life Irritable Bowel Syndrome - Quality Of Life

Patrick DL, Drossman DA, Novartis Pharmaceuticals Corporation et al.

To assess the impact of Irritable Bowel Syndrome and its treatment

Therapeutic indications : Irritable Bowel Syndrome

default distrib

IBS-SSS / Irritable Bowel Syndrome Severity Scoring System Irritable Bowel Syndrome Severity Scoring System

Francis CY, Morris J, Whorwell PJ et al.

To assess and investigate Irritable Bowel Syndrome

Therapeutic indications : Irritable Bowel Syndrome

default distrib

IBSQoL / Irritable Bowel Syndrome Quality of Life Questionnaire Irritable Bowel Syndrome Quality of Life Questionnaire

GlaxoSmithKline Research & Development Limited et al.

To assess HRQoL in patients with irritable bowel syndrome

Therapeutic indications : Irritable Bowel Syndrome

default distrib

ICQ and ICQ-S / Inhaled Corticosteroid Questionnaire Inhaled Corticosteroid Questionnaire

van der Molen T, Foster JM et al.

To measure patients' inhaled corticosteroids (ICS) related side effect perceptions

Therapeutic indications : Asthma, Pulmonary Disease, Chronic Obstructive

default distrib

IDS-SR and IDS-C / Inventory of Depressive Symptomatology Inventory of Depressive Symptomatology

Rush AJ et al.

To assess depressive symptom severity [ These assessments can be used to screen for depression, although they have been used predominantly as measures of symptom severity ]

Therapeutic indications : Depression

default distrib

IEQ / Injustice Experience Questionnaire Injustice Experience Questionnaire

Sullivan MJ, Adams H, Horan S, Maher D, Boland D, Gross R et al.

To assess perceive injustice associated with injury

Therapeutic indications : Injuries, Musculoskeletal Pain

default distrib

IEQ-SF / Injustice Experience Questionnaire - Short Form Injustice Experience Questionnaire - Short Form

Sullivan MJ, Adams H, Horan S, Maher D, Boland D, Gross R et al.

To assess perceptions of injustice associated with the experience of debilitating health and mental health conditions

Therapeutic indications : Chronic Diseases, Musculoskeletal Pain, Depressive Disorder, Major

default distrib

IGA/PGA Scale / Investigator’s Global Assessment (or Physician's Global Assessment) Scale Investigator’s Global Assessment (or Physician's Global Assessment) Scale

Rao DB, Georgiev EL, Paul PD, Guzman AB et al.

To evaluate the overall severity of atopic dermatitis

Therapeutic indications : Dermatitis, Atopic

default distrib

INQoL / Individualized Neuromuscular Quality of Life Questionnaire Individualized Neuromuscular Quality of Life Questionnaire

Carr AJ, Rose MR, Vincent KA et al.

To assess health-related quality of life of patient suffering from neuromuscular diseases.

Therapeutic indications : Muscular Diseases

default distrib

IRLS / International Restless Legs Syndrome Study Group Rating Scale International Restless Legs Syndrome Study Group Rating Scale

Allen RP, Walters AS et al.

To measure the severity of Restless Legs Syndrome (RLS)

Therapeutic indications : Restless Legs Syndrome

default distrib

ISI / Insomnia Severity Index Insomnia Severity Index

Morin CM et al.

To quantify the patient's perception of insomnia severity, and its impact on daytime functioning

Therapeutic indications : Sleep Disorders (includes apnea)

default distrib

ISL / Index of Sexual Life Index of Sexual Life

Pfizer (France), Mapi et al.

To measure the impact of erectile dysfunction on female partners' sexuality

Therapeutic indications : Erectile Dysfunction, Female Sexuality

default distrib

ITEQ / Insulin Treatment Experience Questionnaire Insulin Treatment Experience Questionnaire

Sanofi Aventis, University of Greifswald et al.

To assess subtle but clinically relevant differences in treatment experiences and satisfaction over a wide range of currently available insulin therapy regimens

Therapeutic indications : Diabetes Mellitus, Type 2

default distrib

ITSEA / Infant Toddler Social Emotional Assessment Infant Toddler Social Emotional Assessment

Briggs-Gowan MJ, Carter AS et al.

To measure multiple dimensions of social-emotional problems and competencies in 1- to 3-year-old children

Therapeutic indications : Developmental Disabilities

default distrib

ITSQ / Insulin Treatment Satisfaction Questionnaire Insulin Treatment Satisfaction Questionnaire

Novo Nordisk (Denmark) et al.

To measure insulin treatment satisfaction, applicable to a wide range of insulin therapies

Therapeutic indications : Diabetes Mellitus